Schroder Investment Management Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-195,307
Closed -$8.23M 1260
2023
Q2
$8.23M Sell
195,307
-347,287
-64% -$14M 0.01% 679
2023
Q1
$19.3M Sell
542,594
-122,742
-18% -$4.45M 0.03% 479
2022
Q4
$24.4M Buy
665,336
+111,568
+20% +$4.41M 0.04% 407
2022
Q3
$26.1M Buy
553,768
+35,621
+7% +$2.3M 0.04% 377
2022
Q2
$37.4M Buy
518,147
+16,143
+3% +$1.18M 0.06% 318
2022
Q1
$41M Sell
502,004
-145,262
-22% -$12.3M 0.05% 330
2021
Q4
$66.5M Sell
647,266
-11,300
-2% -$1.09M 0.09% 232
2021
Q3
$57.6M Sell
658,566
-101,458
-13% -$9.18M 0.09% 241
2021
Q2
$68M Buy
760,024
+25,382
+3% +$2.14M 0.09% 236
2021
Q1
$55.7M Buy
734,642
+207,211
+39% +$15.6M 0.07% 280
2020
Q4
$35.9M Buy
527,431
+147,987
+39% +$9.23M 0.05% 338
2020
Q3
$21.2M Buy
379,444
+7,021
+2% +$418K 0.03% 424
2020
Q2
$21.7M Sell
372,423
-11,423
-3% -$614K 0.04% 401
2020
Q1
$15.7M Sell
383,846
-119,905
-24% -$7.01M 0.03% 427
2019
Q4
$30M Buy
503,751
+3,479
+0.7% +$187K 0.05% 401
2019
Q3
$26.5M Sell
500,272
-40,644
-8% -$2.09M 0.05% 401
2019
Q2
$27.6M Buy
540,916
+15,675
+3% +$730K 0.05% 377
2019
Q1
$27.2M Sell
525,241
-83,479
-14% -$4.05M 0.05% 398
2018
Q4
$24K Buy
608,720
+34,964
+6% +$1.62M 0.04% 393
2018
Q3
$29.6M Buy
573,756
+117,751
+26% +$5.77M 0.05% 389
2018
Q2
$21.4M Sell
456,005
-130,103
-22% -$5.39M 0.04% 445
2018
Q1
$20.8M Buy
586,108
+49,588
+9% +$1.94M 0.04% 450
2017
Q4
$23.4M Buy
536,520
+175,713
+49% +$8.21M 0.04% 474
2017
Q3
$19M Sell
360,807
-9,751
-3% -$544K 0.03% 493
2017
Q2
$21.6M Buy
370,558
+1,653
+0.4% +$85.9K 0.04% 454
2017
Q1
$16.7M Buy
368,905
+28,384
+8% +$1.41M 0.03% 518
2016
Q4
$17.9M Buy
340,521
+5,321
+2% +$258K 0.03% 516
2016
Q3
$14.9M Sell
335,200
-1,700
-0.5% -$73.7K 0.03% 535
2016
Q2
$12.8M Sell
336,900
-79,700
-19% -$3.5M 0.03% 565
2016
Q1
$16.9M Sell
416,600
-6,000
-1% -$247K 0.04% 509
2015
Q4
$20.5M Sell
422,600
-93,600
-18% -$4.16M 0.04% 457
2015
Q3
$20.6M Sell
516,200
-27,500
-5% -$1.2M 0.04% 453
2015
Q2
$20.7M Buy
543,700
+288,800
+113% +$9.96M 0.04% 458
2015
Q1
$8.14M Buy
254,900
+4,900
+2% +$135K 0.02% 689
2014
Q4
$6.42M Buy
+250,000
New +$5.95M 0.01% 742

Other funds holding SYNH

Schroder Investment Management Group's SYNH Position: Q3 2023 in Review

Schroder Investment Management Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 195,307 shares — an estimated $8.23M sold.

Schroder Investment Management Group first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $68M in Q2 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Schroder Investment Management Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Schroder Investment Management Group sold 195,307 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $8.23M.
  • Schroder Investment Management Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
  • Schroder Investment Management Group's Syneos Health, Inc. Class A Common Stock position peaked at $68M in Q2 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Schroder Investment Management Group's 13F filing for Q3 2023, filed 14 Nov 2023.